Heron Therapeutics | HRTX - العاصمة قرض





العاصمة قرض تغيير تاريخ
ALKERMES USD 1.48B 7.23M 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Eisai JPY 184.6B 49.83B 2026-06
Emergent BioSolutions USD 446.5M 1.7M 2023-12
GlaxoSmithKline GBP 13.95B 65M 2026-06
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 543.51M 1.3M 2026-06
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
Merck USD 51.08B 4.41B 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 363.12M 4.53M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Veracyte USD 0 0 2025-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12